Vaccines Related News
Cold chain challenges solved with collaboration
B Medical Systems has hosted a roundtable event at Medlab Asia – providing insights into the challenges of cold chain systems.
During the Medlab Asia...
Sepsis prevention: The alliance of vaccinations, sanitation, and the vaccine cold chain
Sepsis is a severe bodily reaction to infection, which can cause fever, breathlessness, disorientation, tissue damage, and organ failure, among other symptoms.
While bacterial infections...
UK and BioNTech SE sign landmark deal for cancer vaccine trials
The UK Government has established a historic agreement with German-based BioNTech SE for cancer vaccine trials.
The groundbreaking deal will improve access to cancer vaccine...
Defence Therapeutics granted US patent for vaccine enhancer technology
Discover how the issue of a patent will allow Defence Therapeutics' vaccine enhancer technology to be commercialised.
Defence Therapeutics’ mRNA cancer vaccine testing begins
Canadian biopharmaceutical specialist Defence Therapeutics has announced that testing of its revolutionary AccumTM-linked mRNA cancer vaccine has started.
The performance of Defence’s AccumTM mRNA cancer...
Clinical trial finds temperature-stable TB vaccine safe and effective
A clinical trial testing a freeze-dried, temperature-stable experimental tuberculosis (TB) vaccine in healthy adults found it was safe.
A phase 1 trial, supported by the...
Defence advances to phase I clinical trials of the Accum technology
Defence Therapeutics Inc. is pleased to update its stakeholders on its completed achievements and outline the future milestones for AccumTM set for 2023.
Over the...
NICE recommends three treatments for COVID-19
The National Institute for Health and Care Excellence (NICE) has recommended three treatments for COVID-19 that are cost-effective.
Everyone with COVID-19 at the highest risk...
Evusheld not recommended for vulnerable adults with COVID-19
NICE has not recommended Evusheld for vulnerable adults in England with COVID-19 due to a lack of evidence of its effectiveness.
Evusheld is used to...
Can the BCG vaccine combat cancer and autoimmune diseases?
Researchers have proposed that the 100-year-old BCG vaccine, originally used for tuberculosis, could be effective against cancer and autoimmune diseases.
At the beginning of the...
Defence Therapeutics begins manufacturing of it’s ARM vaccine
Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, is pleased to announce the start...
The TB vaccine does not protect elderly patients from COVID-19
The TB vaccine does not protect the elderly against disease symptoms caused by COVID-19, according to researchers in the Netherlands.
These findings come from a...
74% of UK parents support routine chickenpox vaccine
Almost three-quarters of UK parents would support the chickenpox vaccine being added to the childhood vaccination schedule.
The chickenpox vaccine protects against the varicella-zoster virus...
Defence Therapeutics has melanoma vaccine validated
Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, is pleased to report the validation...
New discovery could lead Epstein-Barr virus vaccines
Researchers from MedUni Vienna have found a specific immune response to the virus Epstein-Barr virus that could help the development of new vaccines.
The research...
Defence Therapeutics launch Accum-mRNA vaccine programme
Defence Therapeutics Inc., a Canadian biopharmaceutical company specialising in the development of immune-oncology vaccines and drug delivery technologies, is pleased to announce the advancement...
COVID-19 infection and vaccination provide protection against omicron BA.5
A study from the University of Lisbon has shown that vaccination and previous COVID-19 infection grants protection against omicron BA.5.
The study was led by...
WHO update guidelines on HPV vaccination
The World Health Organization (WHO) has recently published a paper outlining updates to their recommendations for the human papillomavirus (HPV) vaccine.
Notably, the paper states...
Over 40,000 doses of Oxford’s Ebola vaccine heading to Uganda
University of Oxford’s Ebola vaccine has been manufactured by SII (Serum Institute of India) in just 60 days and doses shipped to Uganda.
Oxford’s Ebola vaccine...
New mRNA cancer vaccine significantly reduces disease
An mRNA cancer vaccine, developed by Moderna and Merck, demonstrated a statistically significant and clinically meaningful reduction in risk of disease recurrence or death.
The...